Working with animals, Penn researchers modified the mRNA vaccine to target C. difficile, an infection that kills 30,000 in ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

so Scharffenberger set out to create an anti-idiotype antibody with the potential to become an RSV vaccine. The first step to ...

Policy, funding, and public apathy hold back the search for more advanced COVID vaccines — but researchers persist and have ...

With millions of mice and rats in US labs alone, scientists can learn a lot of information from their scurrying test subjects ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

The vaccine, which blocks a protein believed to cause the disease from accumulating in the brain, greatly reduced atrophied brain matter in mice with the disease. The team behind the vaccine ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced new findings related to its ...

Working with mice, hamsters, and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 ...

Working with mice, hamsters, and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 vaccine — based on technology also pioneered at Penn — appeared to ...

The same technology that saved millions of lives during the COVID-19 pandemic appears to hold promise against another scourge of infectious disease, according to new research from the University ...